Literature DB >> 32061410

Left Ventricular Pressure-Strain-Derived Myocardial Work at Rest and during Exercise in Patients with Cardiac Amyloidosis.

Tor Skibsted Clemmensen1, Hans Eiskjær2, Fabian Mikkelsen2, Sven-Olof Granstam3, Frank A Flachskampf4, Jens Sørensen5, Steen Hvitfeldt Poulsen2.   

Abstract

BACKGROUND: Left ventricular pressure-strain-derived myocardial work index (LVMWI) is a novel, noninvasive method for left ventricular (LV) function evaluation in relation to LV pressure dynamics. LV global longitudinal strain (LVGLS) has proven benefit for diagnosis and risk stratification in patients with cardiac amyloidosis (CA), but LVGLS does not adjust for loading conditions. The aim of the present study was to characterize LVMWI at rest and during exercise in patients with CA.
METHODS: A total of 155 subjects were retrospectively included. These subjects comprised 100 patients with CA and 55 healthy control subjects. All patients had previously undergone comprehensive two-dimensional echocardiographic examinations at rest. Furthermore, a subgroup 27 patients with CA and 41 control subjects was examined using semisupine exercise stress echocardiography.
RESULTS: Patients with CA had significantly lower LVGLS, LVMWI, and LV myocardial work efficiency (LVMWE) than control subjects (P < .0001 for all). The reduction in LV myocardial performance was more pronounced in the basal segments, which led to significant alterations in the average apical-to-basal segmental ratios between patients with CA and control subjects (LVGLS, 2.6 [1.9 to 4.1] vs 1.3 [1.2 to 1.5]; LVMWI, 2.6 [1.7 to 3.8] vs 1.3 [1.1 to 1.5]; LVMWE, 1.1 [1.0 to 1.3] vs 1.0 [1.0 to 1.1]; P < .0001 for all). The average increase in LVMWI from rest to peak exercise was 1,974 mm Hg% (95% CI, 1,699 to 2,250 mm Hg%; P < .0001) in control subjects and 496 mm Hg% (95% CI, 156 to 835 mm Hg%; P < .01) in patients with CA. The absolute numeric LVGLS increase was 5.6% (95% CI, 3.9% to 7.3%; P < .0001) in control subjects and only 1.2% (95% CI, -0.9% to 3.3%; P = .26) in patients with CA (between groups, P < .0001) from rest to peak exercise. The LVMWI increase in patients with CA was mediated by improvement in the apical segments (P < .0001), whereas there was no significant LVMWI alterations in the midventricular or basal segments. LVMWE remained stable during exercise in control subjects (Δ -0.6%; 95% CI, -2.5% to 1.2%; P = .50) but decreased significantly in patients with CA (Δ -2.5%; 95% CI, -4.8% to -0.2%; P < .05).
CONCLUSIONS: Patients with CA have significantly reduced magnitude of LVMWI compared with healthy control subjects. With exercise, the differences are even more pronounced. Even though LVMWI increased with exercise, LVMWE decreased, suggesting inefficient myocardial energy exploitation in patients with CA.
Copyright © 2019 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac amyloidosis; Exercise echocardiography; Myocardial work; Speckle-tracking imaging; Strain imaging

Year:  2020        PMID: 32061410     DOI: 10.1016/j.echo.2019.11.018

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Quantitative assessment of left ventricular systolic function in patients with systemic lupus erythematosus: a non-invasive pressure-strain loop technique.

Authors:  Xia Li; Huijuan Chen; Meng Han; Yanling Luo; Fengzhen Liu; Lili Chen; Xiaolin Wang; Yu Zhao; Ruirui Kang; Chujun Wang; Chunquan Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-06

Review 2.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

Review 3.  Myocardial Work: Methodology and Clinical Applications.

Authors:  Konstantinos Papadopoulos; Özge Özden Tok; Konstantina Mitrousi; Ignatios Ikonomidis
Journal:  Diagnostics (Basel)       Date:  2021-03-22

4.  Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.

Authors:  Sara Shimoni; Meital Zikri; Dan Haberman; Shay Livschitz; Sagi Tshori; Yacov Fabricant; Valery Meledin; Gera Gandelman; Sorel Goland; Jacob George
Journal:  ESC Heart Fail       Date:  2021-10-26

5.  Myocardial Injury in Multiple Myeloma Patients With Preserved Left Ventricular Ejection Fraction: Noninvasive Left Ventricular Pressure-Strain Myocardial Work.

Authors:  Zhiyue Liu; Li Zhang; Mei Liu; Fang Wang; Yanqiu Xiong; Zhuoqin Tang; Qian Li; Qiuchen Lu; Shichu Liang; Ting Niu; He Huang
Journal:  Front Cardiovasc Med       Date:  2022-01-20

Review 6.  Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes.

Authors:  Emanuele Monda; Giuseppe Palmiero; Michele Lioncino; Marta Rubino; Annapaola Cirillo; Adelaide Fusco; Martina Caiazza; Federica Verrillo; Gaetano Diana; Alfredo Mauriello; Michele Iavarone; Maria Angela Losi; Maria Luisa De Rimini; Santo Dellegrottaglie; Antonello D'Andrea; Eduardo Bossone; Giuseppe Pacileo; Giuseppe Limongelli
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.964

Review 7.  The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications.

Authors:  Dawud Abawi; Tommaso Rinaldi; Alessandro Faragli; Burkert Pieske; Daniel A Morris; Sebastian Kelle; Carsten Tschöpe; Concetta Zito; Alessio Alogna
Journal:  Heart Fail Rev       Date:  2021-05-26       Impact factor: 4.654

8.  Myocardial work index during normal dobutamine stress echocardiography.

Authors:  Marina Leitman; Yoni Balboul; Oleg Burgsdorf; Vladimir Tyomkin; Shmuel Fuchs
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.379

Review 9.  The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.

Authors:  Shaun Khanna; Ivy Wen; Aditya Bhat; Henry H L Chen; Gary C H Gan; Faraz Pathan; Timothy C Tan
Journal:  Front Cardiovasc Med       Date:  2020-10-30

10.  Value of UGT2B7-161 Single Nucleotide Polymorphism in Predicting the Risk of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Who Underwent Pertuzumab Combined with Trastuzumab Therapy by PSL.

Authors:  Jian Li; Hui Luo; Ying-Ying Liu; Li-Xin Chen; Mei-Qin Zhu; Quan-Tong Deng; Dong-Mei Zhu; Zi-Mo Wang; Jin-Feng Xu
Journal:  Pharmgenomics Pers Med       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.